A 67-year-old man with metastatic melanoma and chronic lymphocytic leukemia was inadvertently given a vaccinia melanoma oncolysate vaccination. He developed progressive vaccinia at the site of inoculation. The lesion started to heal only when he was treated with ribavirin. Vaccinia immune globulin was administered and appeared to help control the initial lesion and limit the development of satellite lesions.
Vaccinia virus is a member of the Poxviridae and has been
Fourteen days later, he presented with a weeping erythematous lesion on the right upper arm at the site of vaccination. used as a vaccine against smallpox. Little is known about the origin of vaccinia virus because it was used before there was Cellulitis was diagnosed, and treatment with oral floxacillin sufficient technology to characterize it or standardize its use.
(1 g daily; a penicillinase-resistant penicillin with strong antiIt is thought to have arisen from cowpox virus but was probably staphylococcal activity) was commenced. Two days later, 16 altered by person-to-person passage in the 19th century. It now days after vaccination, he returned with a fever (temperature, has no natural host but can infect and replicate in several 39ЊC), nausea, and an increase in the size of the right upper species including humans. arm lesion. He was admitted to the hospital, and therapy with The site of primary vaccination with vaccinia virus is over intravenous floxacillin (2 g daily) was started; however, he the deltoid region of the upper arm; a bifurcate needle that remained unwell. He was treated with intravenous immunohas been dipped into the vaccine is used. The needle is held globulin (200 mg/kg; Intragam, Commonwealth Serum Laboraperpendicular to the skin and pressed in and out five times. tories). The primary vaccination should result in modified swelling and Physical examination at hospital admission revealed tachytenderness at the site of vaccination, some regional lymphadecardia, flush, and fever (temperature to 39ЊC) as well as an 11 nopathy, and mild fever. The resulting pustular lesion may be 1 18-cm lesion on his right upper arm that was weeping in 4 cm but usually does not exceed 2 cm. The resultant protection areas and partially necrotic (figure 1). There was associated against smallpox, which has not been well characterized, is marked erythema and induration extending over the right shoulprobably due to both cellular and humoral immunity. Complider and down the right flank as well as across the chest to the cations following vaccination have been well described [1] . left shoulder. Progressive vaccinia was diagnosed. He also had lesions of metastatic melanoma on his forehead. There were no other skin lesions and no significant lymphadenopathy or Case Report hepatosplenomegaly. Laboratory studies disclosed the follow-A 67-year-old man with metastatic melanoma and chronic ing values: hemoglobin, 101 g/L (normal, 120-180 g/L); lymphocytic leukemia was inadvertently given a vaccinia melaWBCs, 9. /L). He remained febrile over line MM220 infected with vaccinia produced by the Commonthe ensuing 2 days, and the lesion on his upper arm continued wealth Serum Laboratories (Melbourne). This vaccine is an to enlarge and become necrotic. experimental treatment with the aim of stimulating production Because his lesion was progressing 22 days after the vaccinaof antibodies to melanoma as immunotherapy for metastatic tion and there had been no response to a 1-week course of melanoma [2] .
floxacillin therapy, treatment with intravenous ribavirin (400 mg every 8 hours for 5 days [3] ) was started. Floxacillin therapy was continued. Two days after ribavirin therapy was started, Prevention
Twenty five days after the initial vaccination, he was given birth. On the other hand, cell-mediated immunity is probably critical for localization of the virus to the site of initial inoculaan initial dose of 0.25 mL of vaccinia immune globulin/kg intramuscularly. (A small initial dose was chosen to conserve tion and eradication of the infection from the host [6, 7] . In patients with progressive vaccinia, the lesion at the site the scarce resource because his condition was clinically stable. Immunoglobulin has a long half-life [3-4 weeks], and a second of inoculation fails to heal, becomes necrotic, and gradually spreads locally. Then, new satellite lesions appear elsewhere dose was planned if his condition deteriorated.) His condition continued to improve, and he remained afebrile; no new lesions on the body and also undergo local progressive spread and necrosis. If untreated, the condition is invariably fatal [8] . Howoccurred, and his right upper arm lesion was now fully necrotic and demarcating. He was discharged 2 days later; his medicaever, previously published studies have demonstrated that treatment with vaccinia immune globulin [9] and methisazone [10] tion was oral floxacillin (1 g daily).
At a 2-week follow-up, he was well and afebrile. There were has resulted in survival. Methiazone (N-methylisatin-b-thiosemicarbazone) is an two new small vaccinia lesions on his back; one had healed spontaneously, and one was 0.5 cm in diameter (much smaller antiviral agent that inhibits protein synthesis. It is no longer produced by Burroughs Wellcome (Research Triangle Park, than the initial satellite lesions). His right upper arm lesion was now well demarcated ( figure 3) . The satellite lesions on NC) and is not available. In vitro, methisazone inhibited vaccinia virus-infected cells from synthesizing a ''late'' structural his wrist and leg had healed, and the scalp lesion was crusted and healing; his cervical lymphadenopathy was now nontender viral protein, thus resulting in failure of viral assembly [11] . Ribavirin (1b-D-ribofuranosyl-1H-1,2,4-triazole-3-carboxaand decreased in size. Floxacillin therapy was stopped.
Three days later, he again presented unwell and febrile. Culmide) is an antiviral agent with in vitro activity against a wide range of RNA and DNA viruses, including vaccinia virus [12] . ture of a specimen from the lesion yielded Serratia marcescens, and surgical debridement of the arm lesion was performed.
We treated our patient with 20 mg of ribavirin/kg daily in three divided doses for 5 days, and clinical improvement was noted Therapy with intravenous floxacillin, metronidazole, and gentamicin was started. Six days after skin grafting, he had a cerebrowithin 48 hours of commencing ribavirin therapy (falling temperature and no further increase in the size of the right upper vascular event associated with cerebral metastasis of his melanoma. He was discharged home to the care of his family and arm lesion that had started to become necrotic with evident demarcation from normal skin). However, at this stage, new died of metastatic melanoma 6 weeks later. No postmortem examination was performed.
lesions were noted, and he was treated with vaccinia immune globulin to control the hematogenous spread of infection and the development of satellite lesions.
Discussion
The role of vaccinia immune globulin in the management of progressive vaccinia is controversial. Previous investigators This case illustrates a well-described complication following inoculation of vaccinia virus-progressive vaccinia (vaccinia have suggested that vaccinia immune globulin has little or no effect on the replication of vaccinia virus at the site of inoculanecrosum or vaccinia gangrenosa). Smallpox vaccine is a highly efficacious vaccine that led to the global eradication of tion and has no clinical effect on the resolution of the primary lesion [11] . In a report by Douglas et al. [13] , vaccinia immune smallpox, with the World Health Organization certifying that the world was free of naturally occurring smallpox in 1980 globulin had no effect on the primary lesion but did help in controlling the appearance of satellite lesions. Currently, immu-[4]. As a result of this achievement, very few reports about the management of the complications of vaccinia virus infection noglobulin preparations used for the management of hepatitis B virus, varicella-zoster virus, and measles virus infections have been published after 1980. Progressive vaccinia has been described in patients with immune disorders and represents the have little effect on the established disease but are used as postexposure prophylaxis to prevent infection or limit viremia failure of the host's immune system to limit viral replication to the immediate area of inoculation of the virus [1] . Individuals and ameliorate disease. We used vaccinia immune globulin to control the occurrence of satellite lesions; the number and size with agammaglobulinemia or decreased cell-mediated immunity as a result of congenital immunodeficiency, leukemia, of new lesions both decreased after therapy. For our patient, ribavirin appeared to have an effect on the lymphoma, or the use of immunosuppressive drugs are at risk of progressive vaccinia.
course of the primary lesion; this effect was shown by resolution of fever and cessation of the spread of the lesion within The relative roles of humoral and cell-mediated immunity in controlling the replication of vaccinia virus have not been 48 hours of administration (the lesion had been continuing to spread for the previous 22 days). Furthermore, vaccinia imclearly defined. It is probable that humoral immunity controls initial infection, because it has been observed that it is difficult mune globulin did limit the number and size of new vaccinia lesions, which subsequently formed after ribavirin therapy was to immunize young infants of vaccinia virus-immune mothers [5] . The level of protection against vaccinia virus in these discontinued. These lesions are thought to occur because of
